TAKE Solutions Limited (IN:TAKE)
:TAKE
TAKE Stock Chart & Stats
₹40.52
₹0.00(0.00%)
At close: 4:00 PM EST
₹40.52
₹0.00(0.00%)
Day’s Range― - ―
52-Week Range₹6.70 - ₹49.90
Previous CloseN/A
Volume49.62K
Average Volume (3M)58.94K
Market Cap
₹5.64B
Enterprise Value₹5.75B
Total Cash (Recent Filing)₹1.50M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)131.6
Beta1.35
Next Earnings
May 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding147,934,000
10 Day Avg. Volume129,011
30 Day Avg. Volume58,943
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)5.00
Price to Sales (P/S)0.00
P/FCF Ratio-6.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Life‑sciences Software & Services FocusTAKE’s core business is a niche technology and services play for regulated life‑sciences firms, a structural market with ongoing demand for compliance, clinical and regulatory IT. This specialization supports durable demand for software and consulting as regulatory complexity and digitalization persist.
Balance‑sheet Improvement (FY2025)A return to positive equity and zero reported debt in FY2025 materially improves financial flexibility and reduces immediate solvency risk, enabling the company to fund operations or pursue opportunities without high interest burdens. This change strengthens near‑term durability versus prior negative equity.
Prior Ability To Generate Operating Cash FlowHistorical positive operating cash flow in FY2021–FY2022 shows the business can generate cash from operations when revenue and execution align. That demonstrated cash‑generation capability suggests management can return to self‑funding if core revenues and service delivery recover.
Bears Say
Revenue Collapsed To Zero (FY2025)Reporting zero revenue in FY2025 is a fundamental durability concern: it erodes recurring contract bases, undermines pricing power and scale economics, and makes recovery reliant on rebuilding top‑line demand rather than marginal cost or efficiency moves alone.
Core Operations Remain UnprofitablePersistent EBIT losses indicate the company’s core software and services are not producing sustainable operating profits. Relying on non‑operating items to report net income is not durable and leaves the business exposed if one‑time gains or financial adjustments reverse.
Volatile And Recently Negative Operating Cash FlowIrregular cash generation and a return to negative operating cash flow in FY2025 impair the company’s ability to self‑fund investments and absorb shocks. Volatility increases reliance on external financing and constrains strategic execution, weakening long‑term resilience.
TAKE Solutions Limited News
TAKE FAQ
What was TAKE Solutions Limited’s price range in the past 12 months?
TAKE Solutions Limited lowest stock price was ₹6.70 and its highest was ₹49.90 in the past 12 months.
What is TAKE Solutions Limited’s market cap?
TAKE Solutions Limited’s market cap is ₹5.64B.
When is TAKE Solutions Limited’s upcoming earnings report date?
TAKE Solutions Limited’s upcoming earnings report date is May 28, 2026 which is in 61 days.
How were TAKE Solutions Limited’s earnings last quarter?
TAKE Solutions Limited released its earnings results on Feb 14, 2026. The company reported ₹0.076 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.076.
Is TAKE Solutions Limited overvalued?
According to Wall Street analysts TAKE Solutions Limited’s price is currently Overvalued.
Does TAKE Solutions Limited pay dividends?
TAKE Solutions Limited pays a Semiannually dividend of ₹0.4 which represents an annual dividend yield of N/A. See more information on TAKE Solutions Limited dividends here
What is TAKE Solutions Limited’s EPS estimate?
TAKE Solutions Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TAKE Solutions Limited have?
TAKE Solutions Limited has 147,934,000 shares outstanding.
What happened to TAKE Solutions Limited’s price movement after its last earnings report?
TAKE Solutions Limited reported an EPS of ₹0.076 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.976%.
Which hedge fund is a major shareholder of TAKE Solutions Limited?
Currently, no hedge funds are holding shares in IN:TAKE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TAKE Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe. The company offers IP-driven and technology backed solutions, consulting, and functional services across clinical, regulatory, and safety for life sciences industry. It also provides clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. In addition, the company provides IT infrastructure and support, supply chain management, engineering, designing, and sourcing services. It serves to large and small innovator biopharmaceutical and devices companies, as well as generics manufacturers. The company was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.
Technical Analysis
BSL Ltd
―
Dhruv Consultancy Services Ltd.
―
Odigma Consultancy Solutions Limited
―
SecMark Consultancy Ltd.
―
Semac Consultants Ltd
―